CIDRAP newsletters options
A study in healthcare workers underscores the need for careful screening.
An influenza research network established by the National Institutes of Health (NIH) in 2007 to help answer key questions during outbreaks now has a response plan to help it prepare for new challenges. A team led by the Centers for Infectious Disease Research and Development (CIDRAP), which publishes CIDRAP News, detailed the plan yesterday in Influenza and Other Respiratory Viruses.
New testing studies reveal more about spread in some US communities, and overseas, cases rose steadily in many countries, especially Russia and Japan.
Yesterday was the deadliest day yet in the US outbreak, with 4,951 new deaths.
Part of the problem is too few novel antibiotic candidates, according to Pew.
As global deaths approach 150,000, the WHO says it will issue guidance over the weekend on serologic testing.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Antibiotic use in Chinese hospitals rose by nearly 40% from 2011 through 2018, with a troubling rise in the use of last-resort antibiotics, according to a study this week in Antimicrobial Resistance and Infection Control.
The Democratic Republic of the Congo (DRC) has tracked two new Ebola cases, raising the outbreak's resurgence total to five cases that have emerged just as the country was poised to announce an end to an outbreak that began in August 2018.
Laboratory-confirmed influenza activity in the United States is now low, and influenza-like illness (ILI) activity is lower but still elevated, the Centers for Disease Control and Prevention (CDC) said today in its latest FluView report.
President Trump is poised to announce plans to reopen the economy.
Japan and Indonesia are grappled with rising case numbers.
The data suggest that identifying another pathogen might not rule out COVID-19.
A study of new mothers in 16 US states and 1 city published yesterday in Emerging Infectious Diseases found that, while over 90% of women pregnant during the 2016 Zika virus outbreak knew about the risks posed by infection, only half discussed it with their doctors.
A mosquito-borne virus, Zika can cause microcephaly (abnormally small head) and other defects in babies born to infected women.
The World Health Organization (WHO) today fleshed out more details on the three recently reported Ebola cases in the Democratic Republic of the Congo (DRC) city of Beni, noting that all are epidemiologically linked and that samples have been sent for genetic testing to see if they are part of a known transmission chain.
The US announcement of the withdrawal of WHO funding brings widespread criticism.
Scientists are sifting through which of dozens of serologic tests are going to be useful for assessing how many people have been exposed. But only one test has been reviewed by the FDA.
For the past 10 days, the US death toll has grown by at least 1,000 fatalities per day.
From 2% to 5% of infected healthcare workers required intensive care.
Each year, norovirus causes about 900 deaths, 110,000 hospitalizations, 2.3 million clinic visits, and 470,000 emergency department (ED) visits, at an annual healthcare cost of $430 million to $720 million, providing a substantial opportunity for a vaccine, according to a study in Clinical Infectious Diseases.
Point prevalence surveys at high-acuity long-term care facilities in Chicago indicate that ventilator-capable skilled nursing facilities (vSNFs) are particularly vulnerable to Candida auris, a research team led by the Chicago Department of Public Health reported yesterday in Clinical Infectious Diseases.
